292,410 Shares in Phibro Animal Health Corporation $PAHC Acquired by Ranger Investment Management L.P.

Ranger Investment Management L.P. purchased a new stake in Phibro Animal Health Corporation (NASDAQ:PAHC) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 292,410 shares of the company’s stock, valued at approximately $9,182,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Cvfg LLC acquired a new stake in shares of Phibro Animal Health in the first quarter worth $2,962,000. Advisors Preferred LLC acquired a new position in shares of Phibro Animal Health during the 1st quarter valued at $2,931,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in shares of Phibro Animal Health during the 1st quarter valued at $1,759,000. Renaissance Technologies LLC boosted its position in Phibro Animal Health by 5.8% during the 1st quarter. Renaissance Technologies LLC now owns 576,735 shares of the company’s stock worth $31,899,000 after purchasing an additional 31,435 shares during the period. Finally, Castleark Management LLC purchased a new stake in Phibro Animal Health during the 1st quarter worth $7,904,000. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Price Performance

Shares of PAHC stock opened at $36.32 on Monday. The firm has a fifty day simple moving average of $33.70 and a 200-day simple moving average of $42.61. The company has a market capitalization of $1.47 billion, a PE ratio of 15.59, a price-to-earnings-growth ratio of 0.51 and a beta of 0.46. Phibro Animal Health Corporation has a twelve month low of $28.25 and a twelve month high of $60.08. The company has a current ratio of 3.17, a quick ratio of 1.26 and a debt-to-equity ratio of 1.97.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 2nd will be issued a $0.12 dividend. The ex-dividend date is Wednesday, September 2nd. This represents a $0.48 dividend on an annualized basis and a yield of 1.3%. Phibro Animal Health’s payout ratio is currently 20.60%.

Wall Street Analyst Weigh In

PAHC has been the topic of several research reports. Weiss Ratings lowered Phibro Animal Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, June 15th. Wall Street Zen downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Citigroup lowered their target price on Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating for the company in a research note on Thursday, May 14th. Finally, Zacks Research downgraded Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 21st. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $42.50.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.